Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05992909 · ClinicalTrials.gov registry record
Prophylactic Lymphovenous Bypass Procedure Following Inguinal Lymphadenectomy: A Prospective Observational Study
A clinical trial of Lymphadenectomy, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05992909 is a study of Lymphadenectomy that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05992909, a study of Lymphadenectomy, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn if LBP can help to prevent lymphedema when it is performed at the time of surgery rather than after a patient has already developed the disease.
Conditions Studied
Interventions
- PROCEDURE Lymphovenous bypass procedure
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-08-02 |
| Est. Completion | 2027-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05992909
The ClinicalTrials.gov registry entry for NCT05992909 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lymphadenectomy appearing as the primary indexed condition, and to 1 intervention - of which Lymphovenous bypass procedure is the first listed.
NCT05992909 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05992909 about?
NCT05992909 is a clinical study titled "Prophylactic Lymphovenous Bypass Procedure Following Inguinal Lymphadenectomy: A Prospective Observational Study". To learn if LBP can help to prevent lymphedema when it is performed at the time of surgery rather than after a patient has already developed the disease.
What is the current status of trial NCT05992909?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2023-08-02. Estimated completion is 2027-08-01.
What conditions does trial NCT05992909 study?
This clinical trial studies the following conditions: Lymphadenectomy.
What interventions are being tested in trial NCT05992909?
The interventions under investigation include: Lymphovenous bypass procedure (PROCEDURE).
Who is sponsoring clinical trial NCT05992909?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05992909 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.